Literature DB >> 12076209

Osteopontin as a biomarker for ovarian cancer.

Anthony O'Regan, Catherine Fleming.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12076209     DOI： 10.1001/jama.287.24.3208

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.

Authors:  Fan Lin; Yuyuan Li; Jie Cao; Shaofeng Fan; Jifeng Wen; Guanghui Zhu; Hong Du; Yanxiao Liang
Journal:  Mol Biol Rep       Date:  2010-12-29       Impact factor: 2.316

Review 2.  Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-06-23       Impact factor: 32.419

Review 3.  Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter.

Authors:  David T Denhardt; Devra Mistretta; Ann F Chambers; Shuba Krishna; Joseph F Porter; Srilatha Raghuram; Susan R Rittling
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.